Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001753926-25-000507
Filing Date
2025-03-28
Accepted
2025-03-27 19:56:18
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K g084734_10k.htm   iXBRL 10-K 1500570
2 EXHIBIT 4.2 ex4-2.htm EX-4.2 28471
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 3439
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 14439
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 13258
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 6077
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 3792
8 EXHIBIT 97.1 ex97-1.htm EX-97.1 45315
14 GRAPHIC img001_v1.jpg GRAPHIC 42517
15 GRAPHIC img002_v1.jpg GRAPHIC 39829
16 GRAPHIC img003_v1.jpg GRAPHIC 25155
17 GRAPHIC img004_v1.jpg GRAPHIC 44127
  Complete submission text file 0001753926-25-000507.txt   6600796

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE lipo-20241231.xsd EX-101.SCH 44851
10 XBRL CALCULATION FILE lipo-20241231_cal.xml EX-101.CAL 44537
11 XBRL DEFINITION FILE lipo-20241231_def.xml EX-101.DEF 153659
12 XBRL LABEL FILE lipo-20241231_lab.xml EX-101.LAB 411522
13 XBRL PRESENTATION FILE lipo-20241231_pre.xml EX-101.PRE 316639
86 EXTRACTED XBRL INSTANCE DOCUMENT g084734_10k_htm.xml XML 685352
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41575 | Film No.: 25781112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)